Myomo (NYSEAMERICAN:MYO) Director Sells $21,150.00 in Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Milton Mayo Morris sold 15,000 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $1.41, for a total value of $21,150.00. Following the transaction, the director owned 208,391 shares of the company’s stock, valued at $293,831.31. This trade represents a 6.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Myomo Price Performance

Shares of NYSEAMERICAN:MYO opened at $1.44 on Monday. The firm has a market capitalization of $57.04 million, a PE ratio of -4.24 and a beta of 1.50. Myomo, Inc. has a 1 year low of $0.60 and a 1 year high of $1.89. The company has a debt-to-equity ratio of 1.98, a current ratio of 2.31 and a quick ratio of 2.01. The firm’s 50-day moving average is $1.26 and its two-hundred day moving average is $1.02.

Myomo (NYSEAMERICAN:MYO) last posted its quarterly earnings data on Wednesday, August 5th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.01. The business had revenue of $11.70 million during the quarter, compared to analyst estimates of $10.35 million. Myomo had a negative net margin of 33.53% and a negative return on equity of 138.85%. Analysts predict that Myomo, Inc. will post -0.32 EPS for the current year.

Institutional Trading of Myomo

Hedge funds and other institutional investors have recently made changes to their positions in the company. XTX Topco Ltd purchased a new stake in Myomo in the fourth quarter valued at approximately $148,000. AQR Capital Management LLC boosted its holdings in shares of Myomo by 47.8% in the fourth quarter. AQR Capital Management LLC now owns 434,376 shares of the company’s stock valued at $395,000 after acquiring an additional 140,427 shares in the last quarter. State Street Corp boosted its holdings in Myomo by 5.1% in the 4th quarter. State Street Corp now owns 399,853 shares of the company’s stock valued at $364,000 after purchasing an additional 19,563 shares in the last quarter. Wells Fargo & Company MN grew its holdings in Myomo by 103.1% during the fourth quarter. Wells Fargo & Company MN now owns 38,707 shares of the company’s stock worth $35,000 after acquiring an additional 19,646 shares during the period. Finally, Jane Street Group LLC acquired a new position in shares of Myomo during the 4th quarter worth $64,000. Institutional investors and hedge funds own 44.99% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Ascendiant Capital Markets boosted their target price on Myomo from $9.50 to $10.00 and gave the stock a “buy” rating in a research note on Monday, June 8th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $10.00.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.